ID
36087
Description
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (Day 0) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (Day 21) This document contains the Drug Screening and Alcohol Breath Test for screening form. It has to be filled in for screening.
Mots-clés
Versions (2)
- 15/04/2019 15/04/2019 -
- 15/04/2019 15/04/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
15 avril 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole, 101468/201
Drug Screening and Alcohol Breath Test for screening
- StudyEvent: ODM
Similar models
Drug Screening and Alcohol Breath Test for screening
- StudyEvent: ODM
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C1444657 (UMLS CUI [1,2])
C1254351 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0429928 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])